Deal Roundup: CD&R said to eye Sanofi’s Opella at €15bn valuation, Bain Capital scrapped Kioxia IPO after huge valuation gap with investors: report

Clayton Dubilier & Rice is in talks to buy a controlling stake in the consumer health business of Sanofi which could value it at up to €15bn.